Unico Pharma Private Limited
About Unico Pharma Private Limited
Data last updated:
Unico Pharma Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 06 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74920UP2014PTC065325. Its GSTIN is 09AAECV8649K1ZJ (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It was formerly known as Vedanta Health Care Private Limited. It is led by directors including Vishal Kumar Jaiswal (Managing Director) and Ritweek Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. A – 487 Sector 46 Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.11 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹1.53 Lakh (net margin 1.4%) and EBITDA of ₹2.36 Lakh (EBITDA margin 2.1%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Unico Pharma Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No. A – 487 Sector 46 Noida, Uttar Pradesh, India – 201301
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Unico Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Unico Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Unico Pharma Private Limited, buy the company report.
Financials of Unico Pharma Private Limited
FY 2025 filings availableUnico Pharma Private Limited reported revenue of ₹1.11 Cr (up 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 30% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unico Pharma Private Limited, buy the company report.
Board of directors of Unico Pharma Private Limited
Unico Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritweek Gupta | Director | 06 Aug 2014 | 12 Years 2 Months | Current |
| Vishal Kumar Jaiswal | Managing Director | 18 May 2015 | 11 Years 5 Months | Current |
| Ritu Jaiswal | Director | 06 Aug 2014 | 12 Years 2 Months | Current |
Auditor
Unico Pharma Private Limited is audited by S.K.Dass& Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.K.Dass& Co. | FY 2023 | 000520C |
Shareholding
The shareholding of Unico Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unico Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Unico Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unico Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Unico Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECV8649K1ZJ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Unico Pharma Private Limited, buy the company report.
Recent activity
Unico Pharma Private Limited has 5 board changes on record since 2014: 3 appointments and 2 cessations. The latest: Richa Jaiswal ceased to be Director on 02 Jan 2020.
Frequently asked questions
Unico Pharma is an active private limited company based in Noida, Uttar Pradesh, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 06 August 2014 (12+ years old) and is registered under CIN U74920UP2014PTC065325.
Unico Pharma has 3 current directors:
- Vishal Kumar Jaiswal - Managing Director
- Ritweek Gupta - Director
- Ritu Jaiswal - Director
The latest financial statements of Unico Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Unico Pharma is 09AAECV8649K1ZJ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Unico Pharma is U74920UP2014PTC065325. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unico Pharma was incorporated on 06 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kanpur.
Richa Jaiswal ceased to be Director on 02 Jan 2020. Vishal Kumar Jaiswal was appointed as Managing Director on 18 May 2015. Champa Jaishwal ceased to be Director on 13 Aug 2014. Unico Pharma has 5 board changes on record in total.
The registered office of Unico Pharma is at H No. A – 487 Sector 46 Noida, Uttar Pradesh, India – 201301.
Unico Pharma operates in the healthcare industry, in the preventive health services segment.
The compliance status of Unico Pharma is compliant as of 18 September 2026. The company is actively filing with the Registrar of Companies.